Cargando...

Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease

Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a complementary marker for traditional clinical markers to improve diagnostic accuracy and also help in developing new pharmacotherapeutic trials. It has been revealed that longitudinal analysis of the whole bra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Farzan, Ali, Mashohor, Syamsiah, Ramli, Rahman, Mahmud, Rozi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3305898/
https://ncbi.nlm.nih.gov/pubmed/22035255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-6-105
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!